This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shen, C.-Y. Articles by Wu, C.-W. Search for Related Content PubMed PubMed Citation Articles by Shen, C.-Y. Articles by Wu, C.-W.

Genome-wide Search for Loss of Heterozygosity Using Laser Capture Microdissected Tissue of Breast Carcinoma: An Implication for Mutator Phenotype and Breast Cancer Pathogenesis

Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan [C. Y. S., Y. L. L., C. H. K., J. C. L., C. W. W.]; Department of Surgery, Tri-Service General Hospital, Taipei 100, Taiwan [J. C. Y.]; Department of Pathology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan [C. T. Y.]; National Health Research Institutes, Taipei 11529, Taiwan [Y. S. J., C. W. W.]; and Department of Surgery, National Taiwan University Hospital, Taipei 100, Taiwan [C. S. H.]

Breast cancer is considered to display a high degree of intratumor heterogeneity, without any obvious morphological and pathological steps to define sequential evolution, and its progression may vary among individual tumors. In an attempt to elucidate these etiological and phenotypic complexities, the present study, based on the fundamental concept that genomic instability is the engine of both tumor progression and tumor heterogeneity, was conducted to test the hypothesis that breast cancer pathogenesis is driven by double-strand break (DSB)-initiated chromosome instability (CIN). The rationale underlying this hypothesis is derived from the clues provided by family breast cancer syndromes, in which susceptibility genes, including p53, ATM, BRCA1 and BRCA2, are involved within the common functional pathway of DSB-related checkpoint/repair. Because genomic deletion caused by DSB is reflected in the genetic mechanism of loss of heterozygosity (LOH), this genome-wide LOH study was conducted, using 100 tumors and 400 microsatellite markers. To minimize the effect of heterogeneity within tumors, the experimental technique of laser capture microdissection was used to ensure that genetic and phenotypic examinations were based on the same tumor cells. Support for our hypothesis comes from the observations that: (a) the extent of DSB-initiated CIN in tumors significantly increased as tumors progressed to poorer grades or later stages; (b) in the sequential steps toward CIN, the loci of p53 and ATM, the key checkpoint genes against DSB, were lost at the earliest stage; and (c) many loci identified to be important in breast tumorigenesis were the genomic sites possibly harboring the genes involved in DSB-related checkpoint/repair (including RAD51, RAD52, and BRCA1) or CIN (including FA-A, FA-D, and WRN), and a higher number of these loci showing LOH was significantly associated with increased level of DSB-initiated CIN (P < 0.0001). Breast cancers are thus considered to be sequentially progressive with CIN. However, CIN might also cause genetic heterogeneity, which was revealed by the findings that LOH at some markers was observed only in the component of ductal carcinoma in situ but not in the invasive component of the same tumors. In addition, some markers were found to preferentially lose at specific tumor grades, implying their contribution to genetic heterogeneity during tumor development. Therefore, this study suggests that breast cancer progression is clonal with regard to CIN, but different breast cancers would present distinct molecular profiles resulting from genetic heterogeneity caused by CIN.

This article has been cited by other articles:

				J.-C. Yu, S.-l. Ding, C.-H. Chang, S.-H. Kuo, S.-T. Chen, G.-C. Hsu, H.-M. Hsu, M.-F. Hou, L. Y. Jung, C.-W. Cheng, et al. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes Carcinogenesis, September 1, 2009; 30(9): 1562 - 1570. [Abstract] [Full Text] [PDF]

				H. M. Kuerer, C. T. Albarracin, W. T. Yang, R. D. Cardiff, A. M. Brewster, W. F. Symmans, N. M. Hylton, L. P. Middleton, S. Krishnamurthy, G. H. Perkins, et al. Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field J. Clin. Oncol., January 10, 2009; 27(2): 279 - 288. [Abstract] [Full Text] [PDF]

				S.-l. Ding, J.-C. Yu, S.-T. Chen, G.-C. Hsu, S.-J. Kuo, Y. H. Lin, P.-E. Wu, and C.-Y. Shen Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility Carcinogenesis, January 1, 2009; 30(1): 43 - 49. [Abstract] [Full Text] [PDF]

				H.-M. Hsu, H.-C. Wang, S.-T. Chen, G.-C. Hsu, C.-Y. Shen, and J.-C. Yu Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2024 - 2032. [Abstract] [Full Text] [PDF]

				G. Maeda, T. Chiba, S. Kawashiri, T. Satoh, and K. Imai Epigenetic Inactivation of I{kappa}B Kinase-{alpha} in Oral Carcinomas and Tumor Progression Clin. Cancer Res., September 1, 2007; 13(17): 5041 - 5047. [Abstract] [Full Text] [PDF]

				D.-T. Bau, Y.-C. Mau, S.-l. Ding, P.-E. Wu, and C.-Y. Shen DNA double-strand break repair capacity and risk of breast cancer Carcinogenesis, August 1, 2007; 28(8): 1726 - 1730. [Abstract] [Full Text] [PDF]

				Y.-L. Lo, J.-C. Yu, S.-T. Chen, G.-C. Hsu, Y.-C. Mau, S.-L. Yang, P.-E. Wu, and C.-Y. Shen Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility Carcinogenesis, May 1, 2007; 28(5): 1079 - 1086. [Abstract] [Full Text] [PDF]

				S.-l. Ding, J.-C. Yu, S.-T. Chen, G.-C. Hsu, and C.-Y. Shen Genetic Variation in the Premature Aging Gene WRN: A Case-Control Study on Breast Cancer Susceptibility Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 263 - 269. [Abstract] [Full Text] [PDF]

				S. J. Shin, E. Hyjek, E. Early, and D. M. Knowles Intratumoral Heterogeneity of HER-2/neu in Invasive Mammary Carcinomas Using Fluorescence In-Situ Hybridization and Tissue Microarray International Journal of Surgical Pathology, October 1, 2006; 14(4): 279 - 284. [Abstract] [PDF]

				M.-F. Tsai, C.-C. Wang, G.-C. Chang, C.-Y. Chen, H.-Y. Chen, C.-L. Cheng, Y.-P. Yang, C.-Y. Wu, F.-Y. Shih, C.-C. Liu, et al. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. J Natl Cancer Inst, June 21, 2006; 98(12): 825 - 838. [Abstract] [Full Text] [PDF]

				F. Elstrodt, A. Hollestelle, J. H.A. Nagel, M. Gorin, M. Wasielewski, A. van den Ouweland, S. D. Merajver, S. P. Ethier, and M. Schutte BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants Cancer Res., January 1, 2006; 66(1): 41 - 45. [Abstract] [Full Text] [PDF]

				R. E. Ellsworth, D. L. Ellsworth, D. M. Neatrour, B. Deyarmin, S. M. Lubert, M. J. Sarachine, P. Brown, J. A. Hooke, and C. D. Shriver Allelic Imbalance in Primary Breast Carcinomas and Metastatic Tumors of the Axillary Lymph Nodes Mol. Cancer Res., February 1, 2005; 3(2): 71 - 77. [Abstract] [Full Text] [PDF]

				M. Nessling, K. Richter, C. Schwaenen, P. Roerig, G. Wrobel, S. Wessendorf, B. Fritz, M. Bentz, H.-P. Sinn, B. Radlwimmer, et al. Candidate Genes in Breast Cancer Revealed by Microarray-Based Comparative Genomic Hybridization of Archived Tissue Cancer Res., January 15, 2005; 65(2): 439 - 447. [Abstract] [Full Text] [PDF]

				M Lacroix, R-A Toillon, and G Leclercq Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics Endocr. Relat. Cancer, September 1, 2004; 11(3): 497 - 522. [Abstract] [Full Text] [PDF]

				D.-T. Bau, Y.-P. Fu, S.-T. Chen, T.-C. Cheng, J.-C. Yu, P.-E. Wu, and C.-Y. Shen Breast Cancer Risk and the DNA Double-Strand Break End-Joining Capacity of Nonhomologous End-Joining Genes Are Affected by BRCA1 Cancer Res., July 15, 2004; 64(14): 5013 - 5019. [Abstract] [Full Text] [PDF]

				B. L. Schlechter, Q. Yang, P. S. Larson, A. Golubeva, R. A. Blanchard, A. de Las Morenas, and C. L. Rosenberg Quantitative DNA Fingerprinting May Distinguish New Primary Breast Cancer From Disease Recurrence J. Clin. Oncol., May 15, 2004; 22(10): 1830 - 1838. [Abstract] [Full Text] [PDF]

				Z. C. Wang, M. Lin, L.-J. Wei, C. Li, A. Miron, G. Lodeiro, L. Harris, S. Ramaswamy, D. M. Tanenbaum, M. Meyerson, et al. Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers Cancer Res., January 1, 2004; 64(1): 64 - 71. [Abstract] [Full Text] [PDF]

				F. Lerebours, P. Bertheau, I. Bieche, L.-F. Plassa, M.-H. Champeme, K. Hacene, C. Toulas, M. Espie, M. Marty, and R. Lidereau Two Prognostic Groups of Inflammatory Breast Cancer Have Distinct Genotypes Clin. Cancer Res., September 15, 2003; 9(11): 4184 - 4189. [Abstract] [Full Text] [PDF]

				R. E. Ellsworth, D. L. Ellsworth, S. M. Lubert, J. Hooke, R. I. Somiari, and C. D. Shriver High-Throughput Loss of Heterozygosity Mapping in 26 Commonly Deleted Regions in Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 915 - 919. [Abstract] [Full Text] [PDF]

				W. Zhu, W. Qin, H. Ehya, J. Lininger, and E. Sauter Microsatellite Changes in Nipple Aspirate Fluid and Breast Tissue from Women with Breast Carcinoma or Its Precursors Clin. Cancer Res., August 1, 2003; 9(8): 3029 - 3033. [Abstract] [Full Text] [PDF]

				Y.-P. Fu, J.-C. Yu, T.-C. Cheng, M. A. Lou, G.-C. Hsu, C.-Y. Wu, S.-T. Chen, H.-S. Wu, P.-E. Wu, and C.-Y. Shen Breast Cancer Risk Associated with Genotypic Polymorphism of the Nonhomologous End-Joining Genes: A Multigenic Study on Cancer Susceptibility Cancer Res., May 15, 2003; 63(10): 2440 - 2446. [Abstract] [Full Text] [PDF]

				C. R. Holst, G. J. Nuovo, M. Esteller, K. Chew, S. B. Baylin, J. G. Herman, and T. D. Tlsty Methylation of p16INK4a Promoters Occurs in Vivo in Histologically Normal Human Mammary Epithelia Cancer Res., April 1, 2003; 63(7): 1596 - 1601. [Abstract] [Full Text] [PDF]

				S. Chang, C. M. Khoo, M. L. Naylor, R. S. Maser, and R. A. DePinho Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression Genes & Dev., January 1, 2003; 17(1): 88 - 100. [Abstract] [Full Text] [PDF]

				E. V. Schmidt Genes Involved in Breast Cancer Progression: Analysis of Global Changes in Gene Expression or Retroviral Tagging? Am. J. Pathol., December 1, 2002; 161(6): 1973 - 1977. [Full Text] [PDF]

				H. Rubin and G. R. Anderson Correspondence re: G. Anderson et al., Intrachromosomal Genomic Instability in Human Sporadic Colorectal Cancer Measured by Genome-Wide Allelotyping and Inter-(Simple Sequence Repeat) PCR. Cancer Res., 61: 8274-8283, 2001. Cancer Res., November 1, 2002; 62(21): 6350 - 6351. [Full Text] [PDF]

				Z. Li, Z. H. Meng, A. Sayeed, R. Shalaby, B.-M. Ljung, and S. H. Dairkee Genome-wide Allelotyping of a New in Vitro Model System Reveals Early Events in Breast Cancer Progression Cancer Res., October 15, 2002; 62(20): 5980 - 5987. [Abstract] [Full Text] [PDF]

				U. Novak, E. Oppliger Leibundgut, J. Hager, D. Muhlematter, M. Jotterand, C. Besse, N. Leupin, D. Ratschiller, J. Papp, G. Kearsey, et al. A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL) Blood, August 13, 2002; 100(5): 1787 - 1794. [Abstract] [Full Text] [PDF]

				N. Franco, S.-F. Picard, F. Mege, L. Arnould, and S. Lizard-Nacol Absence of Genetic Abnormalities in Fibroadenomas of the Breast Determined at p53 Gene Mutations and Microsatellite Alterations Cancer Res., November 1, 2001; 61(21): 7955 - 7958. [Abstract] [Full Text] [PDF]

				G. R. Anderson, B. M. Brenner, H. Swede, N. Chen, W. M. Henry, J. M. Conroy, M. J. Karpenko, J.-P. Issa, J. D. Bartos, J. K. Brunelle, et al. Intrachromosomal Genomic Instability in Human Sporadic Colorectal Cancer Measured by Genome-Wide Allelotyping and Inter-(Simple Sequence Repeat) PCR Cancer Res., November 1, 2001; 61(22): 8274 - 8283. [Abstract] [Full Text] [PDF]

				A. Maitra, I. I. Wistuba, C. Washington, A. K. Virmani, R. Ashfaq, S. Milchgrub, A. F. Gazdar, and J. D. Minna High-Resolution Chromosome 3p Allelotyping of Breast Carcinomas and Precursor Lesions Demonstrates Frequent Loss of Heterozygosity and a Discontinuous Pattern of Allele Loss Am. J. Pathol., July 1, 2001; 159(1): 119 - 130. [Abstract] [Full Text] [PDF]

				L. A. Loeb A Mutator Phenotype in Cancer Cancer Res., April 1, 2001; 61(8): 3230 - 3239. [Abstract] [Full Text]